Results

1–8 of 8 results for topical

Efficacy and Safety Outcomes Over 12 Weeks With OCS-01 Eye Drops in DME From DIAMOND-Stage 1 Trial:Focus on Subgroup by Prior Treatment Status
Baruch D. Kuppermann, MD, PhD
Annual Meeting Talks
2025
Can We Prevent Posterior Synechia Formation Using a Topical Short-Acting Mydriatic in Combined Phacoemulsificationâ€“Pars Plana Vitrectomy Surgery? Prospective Study
On Demand Cases, Courses, and Papers
2022
Survey of Intravitreal Injection Technique Among Retina Specialists in Mexico
Gabriela Lopezcarasa Hernandez, MD
On Demand Cases, Courses, and Papers
2021
Efficacy and Safety of ‘Dropless Vitrectomy Surgery’ and Comparison of Outcomes to Standard of Care Topical Therapy
K. V. Chalam, MD, PhD, MBA, FRCS(C), FASRS
Annual Meeting Talks
2021
Effect of Adjuvant Topical Dorzolamide-Timolol Versus Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
Jason Hsu, MD
On Demand Cases, Courses, and Papers
2020
Topical anti-inflammatory therapy without vitrectomy for closure of full-thickness macular holes secondary to cystoid macular edema
Amol D Kulkarni, MD, FASRS
On Demand Cases, Courses, and Papers
2019
Single Intraoperative Subconjunctival Triamcinolone Acetonide Injection Versus 4-6-Week Topical Steroid Taper Following Vitreoretinal Surgery
Elizabeth A Atchison, MD
Annual Meeting Talks
2018
Single Intraoperative Subconjunctival Triamcinolone Acetonide Injection Versus 4-6-Week Topical Steroid Taper Following Vitreore
Elizabeth A Atchison, MD
Updates from the Field
2018